EP 1117407 A1 20010725 - ORAL DOSAGE FORMULATIONS COMPRISING (2S, 3S,5R)-2-(3,5-DIFLUOROPHENYL) -3,5-DIMETHYL-2-MORPHOLINOL AND AN EFFECTIVE STABILIZING AMOUNT OF ALGINIC ACID
Title (en)
ORAL DOSAGE FORMULATIONS COMPRISING (2S, 3S,5R)-2-(3,5-DIFLUOROPHENYL) -3,5-DIMETHYL-2-MORPHOLINOL AND AN EFFECTIVE STABILIZING AMOUNT OF ALGINIC ACID
Title (de)
ORALE VERABREICHUNGSFORM ENTHALTEND (2S, 3S,5R)-2-(3,5-DIFLUOROPHENYL) -3,5-DIMETHYL-2-MORPHOLINOL UND EINE STABILISIERENDE MENGE AN ALGINSAURE
Title (fr)
FORMES POSOLOGIQUES A ADMINISTRATION PAR VOIE ORALE CONTENANT LE COMPOSE (2S,3S,5R)-2-(3,5-DIFLUOROPHENYL)-3,5-DIMETHYL-2-MORPHOLINOL ET UNE QUANTITE STABILISANTE EFFICACE D'ACIDE ALGINIQUE
Publication
Application
Priority
- EP 9907117 W 19990924
- US 10211298 P 19980928
Abstract (en)
[origin: WO0018406A1] This invention provides discrete oral dosage forms, typically tablets or capsules, containing (2S,3S,5R)-2-(3,5-difluorophenyl)-3,5-dimethyl-2-morpholinol or a physiologically acceptable salt or solvate thereof, or a solvate of said salt, and an effective stabilizing amount of alginic acid. These dosage forms are useful for preventing or treating attention deficit hyperkinetic disorder or depression, or in the treatment of addiction to nicotine-containing products, especially tobacco-containing products, such as aiding in smoking cessation.
IPC 1-7
IPC 8 full level
A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 9/48 (2006.01); A61K 31/5375 (2006.01); A61K 47/10 (2006.01); A61K 47/12 (2006.01); A61K 47/14 (2006.01); A61K 47/26 (2006.01); A61K 47/36 (2006.01); A61P 25/14 (2006.01); A61P 25/24 (2006.01); A61P 25/34 (2006.01)
CPC (source: EP KR)
A61K 9/205 (2013.01 - EP); A61K 31/5375 (2013.01 - EP KR); A61K 47/36 (2013.01 - EP); A61P 25/14 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/34 (2017.12 - EP)
Citation (search report)
See references of WO 0018406A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0018406 A1 20000406; AR 022673 A1 20020904; AU 6087399 A 20000417; BR 9914096 A 20010731; CA 2345638 A1 20000406; CN 1328459 A 20011226; CZ 20011142 A3 20010912; EP 1117407 A1 20010725; HU P0103459 A2 20020128; IL 142054 A0 20020310; JP 2002525328 A 20020813; KR 20010075385 A 20010809; MA 26693 A1 20041220; NO 20011555 D0 20010327; NO 20011555 L 20010327; PE 20001087 A1 20001020; PL 346877 A1 20020311; TR 200100863 T2 20010723
DOCDB simple family (application)
EP 9907117 W 19990924; AR P990104841 A 19990924; AU 6087399 A 19990924; BR 9914096 A 19990924; CA 2345638 A 19990924; CN 99813675 A 19990924; CZ 20011142 A 19990924; EP 99947420 A 19990924; HU P0103459 A 19990924; IL 14205499 A 19990924; JP 2000571924 A 19990924; KR 20017003874 A 20010327; MA 25782 A 19990923; NO 20011555 A 20010327; PE 00097699 A 19990927; PL 34687799 A 19990924; TR 200100863 T 19990924